Wasia Ullah Science Reviews - Biology, 2025, 4(2), 1-11
2
13. Coleman, M., Foster, G. M., & Deb, R. M. (2022). Integrated vector management for leishmaniasis
control. PLoS Neglected Tropical Diseases, 16(7), e0010560.
14. Dawn. (2023, June 12). Balochistan remains most deprived province, Punjab least: Report.
15. Durrani, A. B., Mehmood, N., & Rahim, F. (2018). Socioeconomic determinants of cutaneous
leishmaniasis in Pakistan. BMC Public Health, 18(1), 1–9.
16. Durrani, S. J., Khan, I., & Ali, N. (2022). Urbanization and anthroponotic leishmaniasis in Pun-
jab. Parasites & Vectors, 15(1), 1–10.
17. Ejaz, A., Ullah, S., & Afzal, M. S. (2021). Challenges in leishmaniasis control in Pakistan. Infection,
Genetics and Evolution, 93, 104939.
18. Feliciangeli, M. D., Rodriguez, N., & Bravo, A. (2023). Sandfly ecology and housing
structures. Acta Tropica, 238, 106777.
19. Field, A. (2022). Discovering statistics using IBM SPSS statistics (6th ed.). Sage Publications.
20. Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in
meta-analyses. BMJ, 327(7414), 557 –560. https://doi.org/10.1136/bmj.327.7414.557
21. Hotez, P. J., Fenwick, A., & Savioli, L. (2020). Neglected tropical diseases of the Middle
East. PLoS Neglected Tropical Diseases, 4(8), e735.
22. Hussain, M., Munir, S., & Khan, T. A. (2020). Hyperendemic foci of leishmaniasis in Paki-
stan. Journal of Infection in Developing Countries, 14(9), 1020–1027.
23. Intergovernmental Panel on Climate Change. (2022). Climate change 2022: Impacts, adaptation, and
vulnerability. Cambridge University Press.
24. Kayani, B., Sadiq, S., Rashid, H. B., Ahmed, N., Mahmood, A., Khaliq, M. S., ... & Chaudhry, M.
(2021). Cutaneous Leishmaniasis in Pakistan: a neglected disease needing one health strategy. BMC
Infectious Diseases, 21, 1-10. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-
06327-w
25. Khan, S. J., Murtaza, B. N., & Qureshi, N. A. (2022). Sandfly vectors in Pakistan. Parasitology In-
ternational, 87, 102529.
26. Ministry of Health Pakistan. (2024). National report on cutaneous leishmaniasis, 2015–2024.
Government of Pakistan Press.
27. Mondal, D., Alvar, J., & Hasnain, M. G. (2021). Antimonial resistance in South Asia. The Lancet
Infectious Diseases, 21(5), e142–e152.
28. Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... &
Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for systematic reviews. BMJ,
372, n71. https://doi.org/10.1136/bmj.n71
29. Ready, P. D. (2022). Leishmaniasis emergence and climate change. Revue Scientifique et Technique,
29(2), 399–412.
30. Rehman, K., Walochnik, J., & Mischlinger, J. (2021). Psychosocial burden of leishmaniasis. PLoS
Neglected Tropical Diseases, 15(9), e0009092.
31. Silverman, B. W. (2018). Density estimation for statistics and data analysis. Routledge.
32. Steverding, D. (2017). The history of leishmaniasis. Parasites & Vectors, 10(1), 1–10.
https://doi.org/10.1186/s13071-017-2028-5
33. Sundar, S., & Chakravarty, J. (2022). Antimony toxicity in leishmaniasis. Tropical Medicine &
International Health, 27(3), 220–228.